Rheumatologist leads hydroxychloroquine prevention trial for healthcare workers

Hydroxychloroquine may be officially out of favour as a treatment for severe COVID-19, but Australian rheumatologists are pressing on with a COVID-19 prevention trial to investigate the drug for protection of healthcare workers exposed to the virus. Associate Professor Mandana (Mandy) Nikpour, a consultant rheumatologist at St Vincent’s Hospital Melbourne (SVHM) is one of the ...

Already a member?

Login to keep reading.

© 2021 the limbic